CCM
BEAT

Camber Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Camber Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,800,000
Closed -$10.6M – 49
2013
Q2 		$10.6M Buy
+1,800,000
New +$6.06M 1.09% 26

Other funds holding BEAT

CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Camber Capital Management's BEAT Position: Q3 2013 in Review

Camber Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2013, closing a stake of 1,800,000 shares — an estimated $10.6M sold.

Camber Capital Management first reported a position in BEAT in Q2 2013 and held it in 1 quarter. The position peaked at $10.6M in Q2 2013. 75 funds tracked by Wall St. Rank hold BEAT as of Q3 2013.

  • Camber Capital Management reported no remaining BioTelemetry, Inc. position as of Q3 2013 after selling out during the quarter.
  • Camber Capital Management sold 1,800,000 BioTelemetry, Inc. shares in Q3 2013, an estimated $10.6M.
  • Camber Capital Management first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 1 quarter.
  • Camber Capital Management's BioTelemetry, Inc. position peaked at $10.6M in Q2 2013.
  • 75 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2013.

Based on Camber Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.